Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis - No Study Results Posted

Home Search Study Topics Glossary

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

This study has been completed.

Study NCT00111449 Information provided by Amgen

First Received: May 20, 2005 Last Updated: July 17, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given